Zions Bancorporation, National Association’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.4K Buy
134
+40
+43% +$7.85K ﹤0.01% 687
2026
Q1
$18.4K Buy
94
+30
+47% +$5.83K ﹤0.01% 758
2025
Q4
$11.1K Buy
64
+17
+36% +$3.1K ﹤0.01% 829
2025
Q3
$8.96K Buy
47
+12
+34% +$2.13K ﹤0.01% 690
2025
Q2
$6.29K Buy
35
+3
+9% +$521 ﹤0.01% 728
2025
Q1
$5.41K Buy
+32
New +$5.26K ﹤0.01% 734

Other funds holding DGX

Zions Bancorporation, National Association's DGX Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its Quest Diagnostics (DGX) stake by 43% in Q2 2026, buying an estimated $7.85K and bringing the position to 134 shares worth $28.4K. The position accounts for ﹤0.01% of the portfolio, ranked #687.

Zions Bancorporation, National Association first reported a position in DGX in Q1 2025 and has held it in 6 quarters since. 537 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Zions Bancorporation, National Association held 134 shares of Quest Diagnostics worth $28.4K as of Q2 2026.
  • Zions Bancorporation, National Association bought 40 Quest Diagnostics shares in Q2 2026, an estimated $7.85K.
  • Quest Diagnostics made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #687 holding.
  • Zions Bancorporation, National Association first reported a position in Quest Diagnostics in Q1 2025 and has held it in 6 quarters since.
  • 537 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.